Skip to content

Efficacy of dTMS in alcohol dependence

Efficacy of dTMS on craving in alcohol dependence syndrome: An ERP based sham controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051305
Enrollment
30
Registered
2023-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence Health Condition 2: F102- Alcohol dependence

Interventions

Intervention1: Deep Transcranial Magnetic Stimulation (dTMS), Active: The helmet with H7 dTMS coil will be placed on the head of the patient. It will be adjusted such that, the maximal stimulation is

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mental and behavioural disorders due to use of alcohol, dependence syndrome, currently using the substance (F10.24) as per International Classification of disease 10th (ICD-10, DCR)Diagnostic criteria for research. 2. Male gender 3. Age between 18-50 years 4. Ready to give written informed consent 5. Clinical institute withdrawal assessment for alcohol revised (CIWA-ar) score less than 10.

Exclusion criteria

Exclusion criteria: 1. Any other co-morbid substance dependence except nicotine and caffeine. 2. Participants with any co-morbid psychiatric disorder. 3. History of severe withdrawal e.g., convulsions or delirium tremens during abstinence. 4. Color-blind patients 5. Not willing to give written informed consent. 6. Patient with presence of pacemaker or other electronic implants, metal or magnetic objects in the brain.

Design outcomes

Primary

MeasureTime frame
Reduction in scores of craving as rated by Alcohol Craving Questionnaire (ACQ) and Obsessive Compulsive Drinking Scale (OCDS).Timepoint: Reduction in scores of craving as rated by Alcohol Craving Questionnaire (ACQ) and Obsessive Compulsive Drinking Scale (OCDS) as assessed at the end of 2 weeks of dTMS treatment and after 4 weeks.

Secondary

MeasureTime frame
Changes in the amplitude and latency of the P300 component of ERP on Stroop task.Timepoint: Changes in the amplitude and latency of the P300 component of ERP on Stroop task will be assessed before and at end of 2 weeks of dTMS treatment

Countries

India

Contacts

Public ContactDr Aniruddha Mukherjee

Central Institute of Psychiatry

dr_aniruddha@hotmail.com9474413598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026